Raffles Medical Group Ltd
RAFLF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $189,224 | $189,224 | $193,361 | $193,361 |
| % Growth | 0% | -2.1% | 0% | – |
| Cost of Goods Sold | $102,282 | $102,282 | $105,989 | $105,989 |
| Gross Profit | $86,942 | $86,942 | $87,372 | $87,372 |
| % Margin | 45.9% | 45.9% | 45.2% | 45.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $44,804 | $44,804 | $43,095 | $43,095 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $21,331 | $21,331 | $23,669 | $23,669 |
| Operating Expenses | $66,135 | $66,135 | $66,764 | $66,764 |
| Operating Income | $20,807 | $20,807 | $20,608 | $20,608 |
| % Margin | 11% | 11% | 10.7% | 10.7% |
| Other Income/Exp. Net | $1,149 | $1,149 | $1,168 | $1,168 |
| Pre-Tax Income | $21,956 | $21,956 | $21,775 | $21,775 |
| Tax Expense | $5,725 | $5,725 | $6,099 | $6,099 |
| Net Income | $16,054 | $16,054 | $15,800 | $15,800 |
| % Margin | 8.5% | 8.5% | 8.2% | 8.2% |
| EPS | 0.009 | 0.009 | 0.009 | 0.009 |
| % Growth | 0% | 2.4% | 0% | – |
| EPS Diluted | 0.009 | 0.009 | 0.009 | 0.009 |
| Weighted Avg Shares Out | 1,856,168 | 1,856,168 | 1,859,918 | 1,859,918 |
| Weighted Avg Shares Out Dil | 1,856,899 | 1,856,899 | 1,857,852 | 1,857,852 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,149 | $1,149 | $1,168 | $1,168 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $10,379 | $10,379 | $5,640 | $5,640 |
| EBITDA | $31,186 | $31,186 | $27,541 | $27,541 |
| % Margin | 16.5% | 16.5% | 14.2% | 14.2% |